Pendulum Therapeutics (formerly Whole Biome) is a company developing microbiome diagnostics. It leverages a proprietary discovery platform to identify specific microbiome markers and novel interventions. The company’s pipeline includes pre-clinical and clinical trials focused on novel microbiome interventions in key areas such as diabetes and irritable bowel syndrome.